1Dampis U, Baloe A, Vigante D, et al. Prevalence of nosocomial infection in two Lativan hospitals. http://www.eurosurveillance.org/em/vo8no3/o8o3-223.asp.
2Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost and prevention. Infect Control and Hosp Epidemiol, 1996, 17: 552-557.
4Leblebicioglu H. Prevalence of nosocomial infections a intensive care units in Turkey: a multicentre 1-day point prevalence study. Scand Infect Dis, 2004, 36(2): 144-148.
5NNIS. National nosocomial infection surveillance(NNIS) system report, data summary from January 1992 to June 2002. Am J Infect Control, 2002, 30: 458-475.
6Tomee JF;van der Werf TS.Pulmonary aspergillosis[J],2001(5).
7de Marie S.New developments in the diagnosis and management of invasive fungal infections,2000.
8Forster DH;Becker A;Kniehl E.Early diagnosis of invasive aspergillosis,2000.
9VandenBergh MF;Verweij PE;Voss A.Epidemiology of nosocomial fungal infections:invasive aspergillosis and the environment[J],1999(3).
